Results 221 to 230 of about 354,756 (297)

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali, Stephan van Erp, Cornelis Kramers, Cornelis J. Tack, Bastiaan E. de Galan   +4 more
wiley   +1 more source

Anticoagulation management in intracerebral hemorrhage patients with deep vein thrombosis: insights from unsupervised machine learning and nomogram analysis. [PDF]

Front Neurol
Cui C, Yin Q, Long T, Guan H, Lao Z.
europepmc   +1 more source

Wastewater-borne exposure of limnic fish to anticoagulant rodenticides

, 2019
Julia Regnery, Pia Parrhysius, Robert S. Schulz, Christel Möhlenkamp, Georgia Buchmeier, Georg Reifferscheid, Marvin Brinke   +6 more
openalex   +1 more source

Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan’s National Claims Database

Clinical Pharmacology &Therapeutics, EarlyView.
Disproportionality analyses suggested a cardiovascular risk signal for romosozumab, while statistically significant associations were not found in the real‐world database studies. Therefore, a larger comparative study was necessary to examine this signal.
Hotaka Maruyama, Eiko Iwasa, Shinya Watanabe, Tomoaki Hasegawa, Kazuhiro Kajiyama, Taihei Tanaka   +5 more
wiley   +1 more source

Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism. [PDF]

Blood Adv
Ma S, Chang YC, Chiang CH, Song J, Lee YC, Chang KY, Redd RA, Chiasakul T, McCarthy EP, Zwicker JI, Patell R, Leader A.   +11 more
europepmc   +1 more source

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation

Clinical Pharmacology &Therapeutics, EarlyView.
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park, Jae‐Hwan Lee, Jin‐Ok Jeong, Diana A. Gorog, Udaya S. Tantry, Byeong‐Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Jin‐Yong Hwang, Young Bin Song, Sung Gyun Ahn, Jung‐Won Suh, Woong Gil Choi, Jung Rae Cho, Jeehoon Kang, Sang Yeub Lee, Hyo‐Soo Kim, Moo Hyun Kim, Do‐Sun Lim, Eun‐Seok Shin, Paul A. Gurbel, Young‐Hoon Jeong, on behalf of the PTRG‐DES Consortium Investigators   +22 more
wiley   +1 more source

Management of antithrombotic therapy in gonioscopy-assisted transluminal trabeculotomy. [PDF]

Indian J Ophthalmol
Durmuş Ece BŞ.
europepmc   +1 more source

Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta‐analysis of randomized controlled trials

Journal of Thrombosis and Haemostasis, 2016
Y. Umemura, K. Yamakawa, Hiroshi Ogura, Hiroki Yuhara, S. Fujimi   +4 more
semanticscholar   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Is a case of one thromboembolic event one too many? [PDF]

Interv Pain Med
Levi D, Levin J.
europepmc   +1 more source